Iwilfin Tablet
Product Images NDC 78670-150

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Iwilfin (NDC 78670-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Uswm, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Iwilfin 01)

Chemical structure diagram of Eflornithine Hydrochloride showing its molecular configuration with amino, carboxyl, fluorine groups, hydrochloride, and hydration components.*

FDA Label Image

Figure 1 (Iwilfin 02)

A Kaplan-Meier survival curve chart showing Event Free Survival Rate over Time From End of Immunotherapy in years. The chart compares two groups: IWILFIN and Control, with the IWILFIN group consistently showing a higher survival rate. The x-axis ranges from 0 to 12 years, and the y-axis ranges from 0.0 to 1.0 survival probability. The number of subjects at risk for each time point is listed below the x-axis for both groups.*

FDA Label Image

Principal Display Panel (192 mg Bottle Carton)

Packaging label for iwilfin (eflornithine) tablets, each containing 192 mg of eflornithine. The label shows the brand name, tablet strength, and quantity of 100 tablets. It includes storage instructions and distributor information for USWM, LLC in Louisville, KY. The NDC is 78670-150-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.